[{"orgOrder":0,"company":"Farmalider SA","sponsor":"Aspargo Laboratories","pharmaFlowCategory":"D","therapeuticArea":"Endocrinology","country":"","productType":"Small molecule","year":"2020","type":"Acquisition","leadProduct":"Sildenafil Citrate","moa":"","graph1":"Psychiatry\/Psychology","graph2":"Approved","graph3":"Farmalider SA","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Spray","sponsorNew":"Farmalider SA \/ Farmalider","highestDevelopmentStatusID":"12","companyTruncated":"Farmalider SA \/ Farmalider"}]

Find Clinical Drug Pipeline Developments & Deals by Farmalider SA

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Medlab Asia & Asia Health
                          Not Confirmed
                          Medlab Asia & Asia Health
                          Not Confirmed

                          Details : Aspargo’s Sildenafil Oral Spray is an oral liquid suspension of sildenafil citrate administered via a spray pump that dispenses 12.5 mg of sildenafil citrate per push of the pump (referred to as ASP-001) or via an individual single liquid unit dispensi...

                          Brand Name : Viagra

                          Molecule Type : Small molecule

                          Upfront Cash : Undisclosed

                          September 29, 2020

                          Lead Product(s) : Sildenafil Citrate

                          Therapeutic Area : Endocrinology

                          Highest Development Status : Approved

                          Recipient : Aspargo Laboratories

                          Deal Size : Undisclosed

                          Deal Type : Acquisition

                          blank